首页 | 本学科首页   官方微博 | 高级检索  
     

白头翁皂苷B4对临床型奶牛乳房炎疗效和血清炎性因子、免疫因子的影响
引用本文:沈留红,钱柏霖,尤留超,张钺,莘余,吕尚揆,肖劲邦,余树民,苏柘僮,董可,杨世林,冯育林,曹随忠. 白头翁皂苷B4对临床型奶牛乳房炎疗效和血清炎性因子、免疫因子的影响[J]. 浙江农业学报, 2021, 33(7): 1184-1191. DOI: 10.3969/j.issn.1004-1524.2021.07.04
作者姓名:沈留红  钱柏霖  尤留超  张钺  莘余  吕尚揆  肖劲邦  余树民  苏柘僮  董可  杨世林  冯育林  曹随忠
作者单位:1.四川农业大学 动物医学院,动物疫病与人类健康四川省重点实验室/奶牛疾病研究中心,四川 成都 6111302.广西英路维特药物有限公司,广西 荔浦 5410003.四川育强本草生物技术有限公司,四川 成都 6111304.江西中医药大学 中药固体制剂制造技术国家工程研究中心,江西 南昌 330006
基金项目:国家重点研发计划(2018YFD0500900);四川省科技计划(2019YJ0650);江苏农牧科技职业学院产业发展关键技术创新项目(NSF2021ZR01);四川农业大学学科建设双支计划(03572174);四川农业大学本科科研兴趣培养计划(KY2021140)
摘    要:为观察不同剂量白头翁皂苷B4对临床型奶牛乳房炎的疗效,及对血清炎性因子和免疫因子的影响,将36头患临床型乳房炎的奶牛随机分为低、中、高剂量3个试验组,同时选择12头健康奶牛作为对照组.试验组每日分别于颈部肌肉注射白头翁皂苷B40.025、0.05、0.1 mL·kg-1,连续注射6 d,对照组不注射任何药物.试验期间,...

关 键 词:白头翁皂苷B4  临床型奶牛乳房炎  疗效  炎性因子  免疫因子
收稿时间:2020-12-10

Effect of Pulsatilla saponin B4 on treatment efficiency and serum inflammatory and immune factors of dairy cows with clinical mastitis
SHEN Liuhong,QIAN Bolin,YOU Liuchao,ZHANG Yue,SHEN Yu,LYU Shangkui,XIAO Jinbang,YU Shumin,SU Zhetong,DONG Ke,YANG Shilin,FENG Yulin,CAO Suizhong. Effect of Pulsatilla saponin B4 on treatment efficiency and serum inflammatory and immune factors of dairy cows with clinical mastitis[J]. Acta Agriculturae Zhejiangensis, 2021, 33(7): 1184-1191. DOI: 10.3969/j.issn.1004-1524.2021.07.04
Authors:SHEN Liuhong  QIAN Bolin  YOU Liuchao  ZHANG Yue  SHEN Yu  LYU Shangkui  XIAO Jinbang  YU Shumin  SU Zhetong  DONG Ke  YANG Shilin  FENG Yulin  CAO Suizhong
Abstract:To investigate the effects of Pulsatilla saponin B4 on therapeutic effect, serum inflammatory and immune factors in dairy cows with clinical mastitis, 12 healthy dairy cows were selected as the control group, and 36 clinical mastitis cows were selected as the test group and were randomly divided into low, middle and high dose group. Cows in test group were administered with Pulsatilla saponin B4 injection (with doses of 0.025, 0.05, 0.1 mL·kg-1, respectively) through cervical intramuscular injection once a day for 6 days, whereas no medicine was administered in the control group. The effective and cure rates of cows in the test group were recorded, venous blood samples were collected (any day in the control group and the 1st, 3rd, 5th, 7th day in the test group) to measure serum inflammatory and immune factors, as well as milk in the infected quarters on the 1st, 7th, 12th day in the test group to conduct somatic cells count (SCC) and pathogenic microorganism isolation and identification during this experiment. Cows were observed till the 12th day and the therapeutic efficiency was recorded. It was shown that the clinical cure rate and effective rates of low, middle and high dose group were 75.00%, 75.00%, 91.67% and 100%, 100%, 100%, respectively, and the average cure time was 6.33, 6.11, 6.91 d, respectively. The Pulsatilla saponin B4 could significantly (P<0.05) attenuate SCC. Before treatment, 34 out of 36 milk samples were positive with pathogenic microorganism, indicating a detection rate of 94.44%, which mainly consisted of mycoplasma, cocci and Escherichia coli. After treatment, the total negative rate was 52.94%, among which, the negative rate of Bacilli, Staphylococcus chromogenes, Staphylococcus haemolyticus and Escherichia coli were 100%, while the negative rates of mycoplasma, Staphylococcus aureus, Staphylococcus epidermidis and coccus were 69.23%, 60.00%, 50.00% and 33.33%, respectively. Besides, Pulsatilla saponin B4 could significantly (P<0.05) promote the recovery of inflammatory factors CRP, SAA, HP, IL-1α, IL-1β, IL-2, IL-6, IL-8, TNF-α and immune factors IgA, IgD, IgE, IgG, IgM to normal levels.
Keywords:Pulsatilla saponins B4  clinical mastitis  therapeutic effect  inflammatory factors  immune factors  
本文献已被 CNKI 等数据库收录!
点击此处可从《浙江农业学报》浏览原始摘要信息
点击此处可从《浙江农业学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号